ReviewMolecules (Basel, Switzerland)2023

Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update.

Collin Vandemark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.